Hyperaldosteronism among black and white subjects with resistant hypertension
- PMID: 12468575
- DOI: 10.1161/01.hyp.0000040261.30455.b6
Hyperaldosteronism among black and white subjects with resistant hypertension
Abstract
Recent reports suggesting that the prevalence of primary hyperaldosteronism may be higher than historically thought have relied on an elevated plasma aldosterone concentration/plasma renin activity ratio to either diagnose or identify subjects at high risk of having primary hyperaldosteronism and have not included suppression testing of all evaluated subjects. In this prospective study of 88 consecutive patients referred to a university clinic for resistant hypertension, we determined the 24-hour urinary aldosterone excretion during high dietary salt ingestion, baseline plasma renin activity, and plasma aldosterone in all subjects. Primary hyperaldosteronism was confirmed if plasma renin activity was <1.0 ng/mL per hour and urinary aldosterone was >12 microg/24-hour during high urinary sodium excretion (>200 mEq/24-hour). Eighteen subjects (20%) were confirmed to have primary hyperaldosteronism. The prevalence of hyperaldosteronism was similar in black and white subjects. Of the 14 subjects with confirmed hyperaldosteronism who have been treated with spironolactone, all have manifested a significant reduction in blood pressure. In this population, an elevated plasma aldosterone/plasma renin activity ratio (>20) had a sensitivity of 89% and a specificity of 71% with a corresponding positive predictive value of 44% and a negative predictive value of 96%. These data provide strong evidence that hyperaldosteronism is a common cause of resistant hypertension in black and white subjects. The accuracy of these results is strengthened by having done suppression testing of all evaluated subjects.
Similar articles
-
Primary aldosteronism: diagnostic and therapeutic considerations.Curr Cardiol Rep. 2005 Nov;7(6):412-7. doi: 10.1007/s11886-005-0058-7. Curr Cardiol Rep. 2005. PMID: 16256009 Review.
-
The role of aldosterone antagonists in the management of resistant hypertension.Curr Hypertens Rep. 2005 Oct;7(5):343-7. doi: 10.1007/s11906-005-0067-3. Curr Hypertens Rep. 2005. PMID: 16157075 Review.
-
Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.Am J Hypertens. 2005 Jun;18(6):805-12. doi: 10.1016/j.amjhyper.2005.01.002. Am J Hypertens. 2005. PMID: 15925740
-
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55. Clin Med (Lond). 2005. PMID: 15745200 Free PMC article.
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
Cited by
-
Resident-led improvement project to screen for primary hyperaldosteronism in patients with resistant hypertension in an outpatient clinic.BMJ Open Qual. 2024 May 27;13(2):e002611. doi: 10.1136/bmjoq-2023-002611. BMJ Open Qual. 2024. PMID: 38802267 Free PMC article.
-
Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.Endocrine. 2024 Mar 6. doi: 10.1007/s12020-024-03751-1. Online ahead of print. Endocrine. 2024. PMID: 38448679 Review.
-
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review.Hypertens Res. 2024 May;47(5):1103-1119. doi: 10.1038/s41440-023-01538-x. Epub 2024 Jan 16. Hypertens Res. 2024. PMID: 38228750 Review.
-
Captopril challenge test: an underutilized test in the diagnosis of primary aldosteronism.Endocr Connect. 2024 Jan 24;13(3):e230445. doi: 10.1530/EC-23-0445. Print 2024 Mar 1. Endocr Connect. 2024. PMID: 38180077 Free PMC article. Review.
-
Application of a Radiomics Machine Learning Model for Differentiating Aldosterone-Producing Adenoma from Non-Functioning Adrenal Adenoma.Bioengineering (Basel). 2023 Dec 14;10(12):1423. doi: 10.3390/bioengineering10121423. Bioengineering (Basel). 2023. PMID: 38136014 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical